Dendritic cell immunotherapy targeting cancer stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic cell immunotherapy targeting cancer stem cells, covering 2024-04-03 to 2024-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy [Phase 2, Phase 3]